ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717066 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717066; 2) Community: the network communities that were significantly associated with the response to NSC 717066; 3) Molecule: the relationships between components within communities and NSC 717066; 4) MDR: the compounds that were significantly associated with the NSC 717066.

NSC Compound Enrichment Correlation
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0403978426119736 0.2977198
NSC 269760 B8 0.0403978426119736 0.28997092
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0403978426119736 0.46803549
NSC 303812 Aphidicoline glycinate 0.0403978426119736 0.43366942
NSC 303861 L-Cysteine analog 0.0403978426119736 0.5455977
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0403978426119736 0.22568154
NSC 328410 Camptothecin Derivative 0.0403978426119736 0.38008403
NSC 339137 PHYSALOLACTONE 0.0403978426119736 0.5408842
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0403978426119736 0.39909108
NSC 359239 Antibiotic X-14766A 0.0403978426119736 -0.032232596
Total:185  Current:164    [First] [Prev] [Next] [Last]